We used whole-cell recording to identify, for the first time, GABAergic tonic current in subpopulations of substantia gelatinosa neurons in mouse spinal cord slices. Application of the gamma-aminobutyric acid type A receptor antagonist bicuculline revealed tonic currents in 49 of 73 substantia gelatinosa neurons. These tonic currents were dissected into three groups according to their diverse pharmacological properties. In the first group, furosemide failed to block the tonic current while midazolam and propofol potentiated it. In the second group, furosemide blocked the tonic current but midazolam and propofol failed to enhance the current. In the third group, furosemide blocked and 3alpha, 21-dihydroxy-5alpha-pregnan-20-one enhanced the tonic current. The presence of mRNAs for alpha4, alpha5, delta and epsilon subunits in the substantia gelatinosa (reverse-transcriptase polymerase chain reaction) suggest that gamma-aminobutyric acid type A receptors comprising alpha5betaxgamma2, alphaxbetaxepsilon and alpha4betaxdelta subunits are responsible for tonic currents.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.wnr.0000230515.86090.bcDOI Listing

Publication Analysis

Top Keywords

substantia gelatinosa
16
tonic current
16
gelatinosa neurons
12
tonic currents
12
group furosemide
12
gabaergic tonic
8
neurons mouse
8
mouse spinal
8
spinal cord
8
gamma-aminobutyric acid
8

Similar Publications

Spinal cord injuries (SCIs) can lead to severe neuropathic pain and increased risk of myocardial infarction and heart failure; therefore, the use of analgesics against SCI-induced pain should be minimized because of their adverse effects on the cardiovascular system. Ivabradine, a blocker of hyperpolarization-activated cyclic nucleotide-gated cation (HCN) channels, is used as a bradycardic agent, but recent studies focused on it as an analgesic agent for peripheral neuropathic pain. However, the analgesic effects of ivabradine on central neuropathic pain, such as SCI-induced pain, have not been examined.

View Article and Find Full Text PDF

Spinal cord injury (SCI) leads to the development of neuropathic pain. Although a multitude of pathological processes contribute to SCI-induced pain, excessive intracellular calcium accumulation and voltage-gated calcium-channel upregulation play critical roles in SCI-induced pain. However, the role of calcium-channel blockers in SCI-induced pain is unknown.

View Article and Find Full Text PDF

Previous studies have shown that the hyperpolarized cyclic nucleotide gated (HCN) ion channels in the spinal dorsal horn (SDH) might be involved in the development of diabetic neuropathic pain (DNP). Additionally, other studies have shown that the decreased potassium-chloride cotransporter 2 (KCC2) expression in the SDH promotes pain hypersensitivity. Both HCN channels and KCC2 were highly expressed in spinal substantia gelatinosa neurons.

View Article and Find Full Text PDF
Article Synopsis
  • The substantia gelatinosa in the trigeminal subnucleus caudalis is a key area for processing pain signals from the face; this study investigates how naringenin, a natural bioflavonoid, affects GABA responses in this region.
  • Naringenin was shown to enhance GABA-mediated responses in some neurons while suppressing them in others, with these effects depending on the nature (slow or fast) of the GABA response and also being influenced by the concentration of naringenin.
  • Additionally, the response to GABA varied by sex, with juvenile female mice showing predominantly slow responses and juvenile males showing faster responses, suggesting that naringenin could be a potential treatment for orofacial pain tailored to sex differences
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!